David Happel

Director & President & CEO

Director & President & CEO at Sagimet Biosciences Inc., filing insider transactions on 2026-02-10.

Total Purchases

—

0 transactions

Total Sales

$65K

1 transaction

Companies Traded

1 total filings

Active Since

2026-02-10

Last: 2026-02-10

Companies

Sagimet Biosciences Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-10	SGMT	Sale	12.1K	$5.36	$65K	677.6K	SEC ↗